North America’s medical devices industry saw a drop of 32.99% in deal activity during October 2021, when compared with the last 12-month average, led by Boston Scientific’s $1.75bn acquisition of Baylis MedicalInc, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
A total of 65 medical devices industry deals worth $4.7bn were announced for the region in October 2021, against the 12-month average of 97 deals.
Of all the deal types, venture financing saw most activity in October 2021 with 46 transactions, representing a 70.8% share for the region.
In second place was M&A with 16 deals, followed by private equity deals with three transactions, respectively capturing a 24.6% and 4.6% share of the overall deal activity for the month.
In terms of value of deals, M&A was the leading category in North America’s medical devices industry with $2.72bn, while venture financing and private equity deals totalled $1.92bn and $20m, respectively.
North America medical devices industry deals in October 2021: Top deals
The top five medical devices deals accounted for 70.3% of the overall value during October 2021.
The combined value of the top five medical devices deals stood at $3.27bn, against the overall value of $4.7bn recorded for the month.
The top five medical devices industry deals of October 2021 tracked by GlobalData were:
1) Boston Scientific $1.75bn acquisition deal with Baylis MedicalInc
2) The $600m venture financing of Hinge Health by Alkeon Capital,Coatue Management,Tiger Global and Whale Rock Capital Management
3) 3D Systems $400m acquisition deal with Volumetric
4) The $304m venture financing of Medable by Blackstone,GSR Ventures,Sapphire Ventures,Tiger Global Management and Western Technology Investment
5) Integer $220m acquisition deal with Oscor